Astal Laboratories Ltd — Insider Trading, 01-01-1970: Insider Trading / SAST

Astal Laboratories has announced a significant change in its shareholding structure. Following a preferential allotment of convertible warrants and equity shares to non-promoter entities, the company's total equity capital increased substantially from 10.77 Cr to 42.21 Cr. This new share issuance has diluted the stake of existing promoter group entity ACESO RESEARCH LABS LLP. While ACESO's absolute shareholding of 1,959,284 shares remained constant, its percentage stake in Astal Laboratories decreased from 18.19% to 4.64% of the expanded capital. This move indicates a major capital restructuring for Astal Laboratories.